Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TWIST BIOSCIENCE CORPORATION

(TWST)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Twist Bioscience Reports Widened Fiscal Fourth-Quarter Loss as Revenue Rises; Plans to Buy Abveris for Up to $190 Million

11/22/2021 | 09:50am EST


ę MT Newswires 2021
All news about TWIST BIOSCIENCE CORPORATION
01/25Twist Bioscience, Artisan Bio Partner Over Discovery of Antibodies
MT
01/25Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell ..
BU
01/20Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, Febru..
BU
01/10Twist Bioscience's Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leadin..
BU
01/10Twist Bioscience Corporation’s Comprehensive DNA Synthesis Capabilities Expanded a..
CI
01/10Singular Genomics Partners with Twist Bioscience to Enable the Twist NGS Target Enrichm..
CI
01/06Twist Bioscience Creates Custom Whole Exome Target Enrichment Panel for Canine Genomic ..
BU
01/06Twist Bioscience Corporation Creates Custom Whole Exome Target Enrichment Panel for Can..
CI
01/05Twist Bioscience, Revelar Say Data Show RBT-0813 Neutralizes Omicron, Delta Covid-19 Va..
MT
01/05Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 O..
BU
More news
Analyst Recommendations on TWIST BIOSCIENCE CORPORATION
More recommendations
Financials (USD)
Sales 2022 180 M - -
Net income 2022 -246 M - -
Net cash 2022 131 M - -
P/E ratio 2022 -11,1x
Yield 2022 -
Capitalization 2 641 M 2 641 M -
EV / Sales 2022 13,9x
EV / Sales 2023 10,8x
Nbr of Employees 652
Free-Float 92,4%
Chart TWIST BIOSCIENCE CORPORATION
Duration : Period :
Twist Bioscience Corporation Technical Analysis Chart | TWST | US90184D1000 | MarketScreener
Technical analysis trends TWIST BIOSCIENCE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 53,22 $
Average target price 109,67 $
Spread / Average Target 106%
EPS Revisions
Managers and Directors
Emily Marine Leproust Chairman, President & Chief Executive Officer
James M. Thorburn Chief Financial Officer
Aaron K. Sato Chief Scientific Officer
Siyuan Chen Chief Technology Officer
Patrick Weiss Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
TWIST BIOSCIENCE CORPORATION-31.23%2 641
CSL LIMITED-11.13%88 334
WUXI BIOLOGICS (CAYMAN) INC.-7.56%46 306
SAMSUNG BIOLOGICS CO.,LTD.-13.62%43 094
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-7.34%32 656